Mogrify Teams Up With Sangamo To Streamline Cell Immunotherapies
The UK cell conversion startup Mogrify and the US genomic medicine company Sangamo have reached…
23/04/2020 - 3 minutes
Trends & News
Sofinnova Invests €20M in Three Italian Rare Disease Biotechs
The French VC firm Sofinnova Partners has invested €20M in three Italian biotech companies via…
23/04/2020 - 3 minutes
€10M Series A Boosts Cancer Immunotherapy Hitting Tumor Sugar Coating
The French startup Phost’in Therapeutics has raised €10.3M to take its cancer immunotherapy drug against…
22/04/2020 - 3 minutes
Idorsia’s Drug Improves Sleep in First Phase III Trial for Insomnia
The Swiss pharmaceutical company Idorsia has announced that its drug candidate daridorexant significantly improved sleep…
21/04/2020 - 3 minutes
French Biotech Licenses Microbiome Therapeutic to Treat Mood Disorders
The microbiome company LNC Therapeutics has entered into a licensing agreement to use a specific…
17/04/2020 - 3 minutes
Is New Enzyme Technology Key to Solving Society’s Plastic Problem?
A new type of enzyme developed by the French company Carbios can break down more…
17/04/2020 - 4 minutes
Irish Biotech Raises €18M to Develop Non-Viral Cell Therapy Technology
The Irish company Avectas has closed a Series C round to develop cell therapies that…
16/04/2020 - 2 minutes
Healx Deploys AI Drug Discovery Technology Against Rare Nerve Disease
The AI-driven drug repurposing company Healx has teamed up with the global Children’s Tumor Foundation…
15/04/2020 - 3 minutes
Coronavirus Pandemic Bites into European Cancer Research
The UK funder Cancer Research UK and Swedish oncology biotech Alligator Bioscience have independently announced…
10/04/2020 - 4 minutes
Two European Alzheimer’s Disease Treatments Show Promise in Phase II
An epigenetics drug developed by the Spanish biopharmaceutical company Oryzon has reduced aggressive behavior in…
09/04/2020 - 4 minutes
Evotec Makes Move into Gene Therapy with Takeda Deal
German biotech giant Evotec has moved into gene therapy and partnered with Takeda to develop…
08/04/2020 - 3 minutes
UK Biotech’s Arthritis Drug Enters Study in Coronavirus Patients
The UK company Izana Bioscience is freely providing its phase III-ready anti-inflammatory antibody namilumab in…
06/04/2020 - 2 minutes
